["{\n\"step_by_step_thinking\": \"The patient is an 18-month-old boy diagnosed with intermediate-risk neuroblastoma. The parents have refused neoadjuvant chemotherapy due to concerns about side effects. We need to consider the prognosis and potential outcomes without chemotherapy. According to the documents, survival rates drop progressively from 90% in Stage I disease to 2.4% in Stage IV disease. Since the patient has an abdominal mass, it is likely Stage III or IV disease. Surgical removal of the tumor is still the primary therapy; irradiation is of significant benefit in patients with Stage III disease. Without chemotherapy, the prognosis is poor for patients with Stage III and IV diseases.\",\n\"answer_choice\": \"D\""]